Yoon-Jin Lee | Molecular Biology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Yoon-Jin Lee | Molecular Biology | Best Researcher Award

Prof. Yoon-Jin Lee | Molecular Biology | Best Researcher Award

Department of Biochemistry, Soonchunhyang University, South Korea

Dr. Yoon-Jin Lee is a Professor of Biochemistry at Soonchunhyang University College of Medicine, specializing in nutritional biochemistry and molecular mechanisms of cancer metabolism 🧬. Since 2012, Dr. Lee has focused on the complex interplay of cellular processes like apoptosis, autophagy, and metabolic stress in cancer cells. Her research contributes to understanding disease development and potential anticancer treatments. She is actively involved in national projects funded by the National Research Foundation of Korea, aiming to unveil novel ways to combat cancer.

Publication Profile

ORCID

🎓 Education:

Dr. Yoon-Jin Lee holds an advanced degree in Nutritional Biochemistry, with extensive training in molecular biology and cancer research methodologies 🧑‍🎓. Her academic path laid a strong foundation for her work in biochemistry, particularly in understanding cellular mechanisms in oncology.

💼 Experience:

Dr. Lee has served as a professor at the Soonchunhyang University College of Medicine since 2012. With her expertise in cancer metabolism and biochemistry, she leads groundbreaking research projects. Notably, Dr. Lee collaborates on a National Research Foundation of Korea-funded project aimed at decoding cancer cell metabolism and finding treatment methods for chemoresistant cancer types 🧫.

🔬 Research Interests:

Dr. Lee’s research is driven by a commitment to exploring cancer-specific mechanisms of cell fate decision-making, especially through autophagy and apoptosis modulation 🧪. Her work also involves developing drugs targeting chemoresistance in prostate cancer cells and investigating exosome-based diagnostic tools.

🏆 Awards:

Dr. Lee has received accolades for her impactful research in molecular biology, particularly in her studies of cancer metabolism and cell death mechanisms 🏅. Her ongoing contributions to oncology research have been widely recognized in both academic and medical communities.

📚 Publications:

Yoon-Jin Lee, Changyeol Lee, Dongsic Choi, Yeji Lee, and Sang-Han Lee. “Effect of Soy Isoflavone on Prostate Cancer Cell Apoptosis Through Inhibition of STAT3, ERK, and AKT,” Current Issues in Molecular Biology, 2024, 46, pp. 12512–12526. [Cited by X articles].

Yoon-Jin Lee, Eun Sang Kwon, Yong Suk Moon, Jeong-Rang Jo, Dong Rak Kwon. “The Neuroprotective Effects of Peripheral Nerve Microcurrent Stimulation Therapy in a Rat Model of Middle Cerebral Artery Occlusion,” International Journal of Molecular Sciences, 2024, 25, pp. 10034. [Cited by X articles].

Yoon-Jin Lee, TrungHuy Ngo, Hyukjae Choi, Kyung-Sik Song, KyuJoon Lee, Joo-Won Nam. “Evaluating the Anticancer Potential of Polygonum multiflorum Root-Derived Stilbenes Against H2452 Malignant Pleural Mesothelioma Cells,” Fitoterapia, 177, 2024, Article 106135. [Cited by X articles].

Nelly Miteva-Marcheva | Medical Genetics | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Nelly Miteva-Marcheva | Medical Genetics | Best Researcher Award

Assist Prof Dr Nelly Miteva-Marcheva | Medical Genetics | Best Researcher Award

Assist Prof Dr Nelly Miteva-Marcheva, Medical University of Plovdiv, Bulgaria

Dr. Nelly Miteva-Marcheva is a dedicated medical professional specializing in Pediatrics and Medical Genetics. She graduated from the Medical University of Plovdiv in 2015 and became an Assistant Professor at the Department of Medical Genetics in 2019. Since then, she has been committed to integrating advanced training in Medical Genetics into her academic and clinical responsibilities. Dr. Miteva-Marcheva’s research focuses on the intersection of genetics and personalized medicine, aiming to improve patient outcomes through innovative genetic testing and treatments. Her work in implementing DPYD testing for cancer patients and advancing pharmacogenetics in oncology has earned her recognition in the field. With a passion for research and education, Dr. Miteva-Marcheva continues to contribute significantly to the advancement of Medical Genetics.

Publication Profile

Orcid

Strengths for the Award

  1. Academic and Professional Expertise: Dr. Nelly Miteva-Marcheva holds a PhD in Medical Genetics and has specialized training in Pediatrics, showcasing her advanced academic qualifications. Her ongoing role as an Assistant Professor at the Medical University of Plovdiv, coupled with her specialization in Medical Genetics, highlights her commitment to both academia and clinical practice.
  2. Research Contributions: Dr. Miteva-Marcheva has made significant contributions to medical genetics through her published work in high-impact journals, including four publications indexed in SCI and Scopus. Her research on DPYD testing in cancer patients and the application of pharmacogenetics in oncology are noteworthy contributions that have a direct impact on clinical practice and patient care.
  3. Leadership in Research Projects: Dr. Miteva-Marcheva is actively involved in strategic research projects, such as the SRIPD-MUP, indicating her leadership and contribution to advancing medical research in her institution.

Areas for Improvement

  1. Broadened Research Impact: While Dr. Miteva-Marcheva has solid contributions in medical genetics, expanding her research collaborations and contributing to a wider range of interdisciplinary studies could enhance her research impact and visibility.
  2. Editorial and Consultancy Roles: Engaging in editorial appointments and consultancy projects with industry partners would further establish her as a leader in her field, enhancing her candidacy for the Best Researcher Award.

Education 

Dr. Nelly Miteva-Marcheva’s educational journey is marked by a strong foundation in medical sciences and a continuous pursuit of specialized knowledge. She earned her MD from the Medical University of Plovdiv in 2015, laying the groundwork for her medical career. Driven by a passion for pediatrics, she pursued a specialty in this field and obtained her qualification in 2019. Recognizing the importance of genetics in modern medicine, Dr. Miteva-Marcheva further specialized in Medical Genetics starting in 2020. Her dedication to the field led her to complete a PhD in 2024, focusing on groundbreaking research that bridges clinical practice and genetic science. This academic progression not only reflects her commitment to continuous learning but also her desire to make significant contributions to the field of Medical Genetics.

Experience

Dr. Nelly Miteva-Marcheva has amassed a wealth of experience in both clinical practice and academic research. After completing her MD in 2015, she pursued a specialty in Pediatrics, gaining hands-on experience in diagnosing and treating pediatric conditions. In 2019, she joined the Department of Medical Genetics at the Medical University of Plovdiv as an Assistant Professor, where she has been actively involved in teaching, research, and clinical duties. Her role at the university involves integrating her advanced knowledge of genetics into both academic instruction and patient care. Dr. Miteva-Marcheva has contributed to several strategic research projects, including the SRIPD-MUP, and has published multiple articles in high-impact journals. Her experience extends to mentoring students and collaborating with industry professionals, making her a well-rounded expert in Medical Genetics.

Research Focus 

Dr. Nelly Miteva-Marcheva’s research is at the forefront of Medical Genetics, with a particular emphasis on personalized medicine. Her work explores the genetic factors influencing patient responses to treatment, aiming to tailor therapies to individual genetic profiles. One of her notable research areas is the implementation of DPYD testing in cancer patients, which helps to predict and prevent severe toxic reactions to chemotherapy. Additionally, Dr. Miteva-Marcheva’s research in pharmacogenetics focuses on understanding how genetic variations affect drug efficacy and safety, particularly in oncology. Her contributions to these fields not only enhance patient care but also pave the way for more personalized and effective treatment strategies. Dr. Miteva-Marcheva’s ongoing research endeavors continue to push the boundaries of medical science, with the goal of integrating advanced genetic testing into routine clinical practice.

Publication Top Notes

Conclusion

Dr. Nelly Miteva-Marcheva is a highly qualified candidate for the Best Researcher Award. Her expertise in Medical Genetics, strong academic background, and impactful research contributions, particularly in pharmacogenetics and oncology, make her a strong contender for this recognition. While there are opportunities for growth in expanding her research influence and taking on more leadership roles, her current achievements position her well for this award.